Clinical trial

p38 Mitogen-Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma

NCT00676572

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2008-05-01

PhaseN/A

Study timeline

Study start (actual)2008-05-01Date precision: month

Registry last updated2019-10-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

Fiberoptic bronchoscopy; blood testOTHER

Sponsors & collaborators

Imperial College Londonlead sponsor

Royal Brompton & Harefield NHS Foundation Trustcollaborator

Medical Research Councilcollaborator

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00676572 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.